Henry Schein stock holds firm as investors look to latest earnings and market valuation

Published on 09/15/2026 at 15:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock is supported by a market capitalization near USD 9.9 billion as of September 14, 2026, while investors focus on the most recent quarterly figures. The shares trade on Nasdaq with a 52-week range that frames the current valuation.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik — Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein stock (ISIN US42548G1040) represents one of the larger U.S. healthcare distributors on Nasdaq, underpinned by a market capitalization of about USD 9.91 billion as of September 14, 2026 according to CompaniesMarketCap data that compares it with peers such as Petco.CompaniesMarketCap For investors, the current price level and the latest reported earnings remain the key reference points when assessing the stock.

Recent earnings frame Henry Schein stock

Henry Schein, Inc. reported its most recent quarterly results within the last two reporting cycles, covering the first half of 2026 and giving investors an updated view on revenue and earnings trends over that period, as described in summaries of the company’s position in the healthcare and dermatology devices markets.MarketsandMarkets While the detailed figures for each quarter are published directly by Henry Schein through its investor-relations materials, these external overviews confirm its role as a leading distributor of healthcare products and services to dental, medical and veterinary professionals, a business profile that drives its recurring revenue base.

In its latest available annual and interim reports, Henry Schein highlighted multi-billion-dollar revenue streams from its core distribution activities, with earnings reflecting both operating efficiency and ongoing investment in technology and practice-management solutions, according to company and industry summaries.MarketsandMarkets Historically, annual revenue has run at several billion dollars for the most recently reported fiscal years, providing scale that compares favorably with smaller healthcare distributors.

Market capitalization and peer comparison

For a fresh valuation snapshot as of September 14, 2026, CompaniesMarketCap lists Henry Schein with a market capitalization of USD 9.91 billion, more than 13 times the USD 0.69 billion market value reported for Petco on the same date.CompaniesMarketCap This large-cap profile underscores how Henry Schein stock is positioned in the healthcare distribution space relative to mid-cap consumer and pet-care names.

The same overview notes that Petco’s market capitalization fell by 15.54% in 2026, while Henry Schein’s larger scale results in a more robust comparison when investors look at relative performance and resilience in changing market conditions.CompaniesMarketCap For Henry Schein stock, the near-USD-10-billion valuation as of September 14, 2026 is a central metric that many investors use when comparing multiples such as price-to-earnings or price-to-sales with sector peers.

Strategic partnerships and growth drivers

Beyond pure distribution, Henry Schein continues to expand through strategic partnerships that can support future revenue growth. One example is its collaboration with DermaSensor, a company marketing a device designed to assist in skin-cancer detection, which has been integrated into Henry Schein’s procurement channels for office-based practitioners, as described in a fundraising update dated September 15, 2026.Fundraise Insider Such partnerships can create incremental product lines and service offerings that complement Henry Schein’s established distribution network.

Analysts and industry observers see these initiatives, together with Henry Schein’s scale as documented in sector reports, as factors that can influence future earnings trajectories and justify the current market capitalization level relative to smaller healthcare and veterinary players.MarketsandMarkets For equity investors, the combination of distribution scale, recurring demand from medical and dental practices and targeted partnerships is often weighed against risks such as regulatory changes and competitive pressure when evaluating Henry Schein stock.

Henry Schein stock and current trading data

Henry Schein stock trades on Nasdaq under the ticker HSIC, and current market data around September 14, 2026 show the shares changing hands within a defined 52-week range, with the price level sitting between the low and high of that period based on recent trading snapshots for the symbol.TradingView As of the latest completed trading day before publication, Henry Schein’s closing price on Nasdaq in USD, together with the day’s percent change and volume, provides investors with a concrete benchmark to compare against the roughly USD 9.91 billion market capitalization reported on September 14, 2026.